Ulf Johnson1,2, Henrik Engquist3,4, Tim Howells3, Pelle Nilsson3, Elisabeth Ronne-Engström3, Anders Lewén3, Elham Rostami3, Per Enblad3. 1. Department of Neuroscience/Neurosurgery, Uppsala University, Uppsala, Sweden. ulf.johnson@neuro.uu.se. 2. Department of Surgical Sciences/Radiology, Uppsala University, Uppsala, Sweden. ulf.johnson@neuro.uu.se. 3. Department of Neuroscience/Neurosurgery, Uppsala University, Uppsala, Sweden. 4. Department of Surgical Sciences/Anesthesia and Intensive Care, Uppsala University, Uppsala, Sweden.
Abstract
BACKGROUND: Subarachnoid hemorrhage (SAH) is a disease with a high rate of unfavorable outcome, often related to delayed cerebral ischemia (DCI), i.e., ischemic injury that develops days-weeks after onset, with a multifactorial etiology. Disturbances in cerebral pressure autoregulation, the ability to maintain a steady cerebral blood flow (CBF), despite fluctuations in systemic blood pressure, have been suggested to play a role in the development of DCI. Pressure reactivity index (PRx) is a well-established measure of cerebral pressure autoregulation that has been used to study traumatic brain injury, but not extensively in SAH. OBJECTIVE: To study the relation between PRx and CBF in SAH patients, and to examine if PRx can be used to predict DCI. METHODS: Retrospective analysis of prospectively collected data. PRx was calculated as the correlation coefficient between mean arterial blood pressure (MABP) and intracranial pressure (ICP) in a 5 min moving window. CBF was measured using bedside Xenon-CT (Xe-CT). DCI was diagnosed clinically. RESULTS: 47 poor-grade mechanically ventilated patients were studied. Patients with disturbed pressure autoregulation (high PRx values) had lower CBF, as measured by bedside Xe-CT; both in the early (day 0-3) and late (day 4-14) acute phase of the disease. PRx did not differ significantly between patients who developed DCI or not. CONCLUSION: In mechanically ventilated and sedated SAH patients, high PRx (more disturbed CBF pressure autoregulation) is associated with low CBF, both day 0-3 and day 4-14 after onset. The role of PRx as a monitoring tool in SAH patients needs further studying.
BACKGROUND:Subarachnoid hemorrhage (SAH) is a disease with a high rate of unfavorable outcome, often related to delayed cerebral ischemia (DCI), i.e., ischemic injury that develops days-weeks after onset, with a multifactorial etiology. Disturbances in cerebral pressure autoregulation, the ability to maintain a steady cerebral blood flow (CBF), despite fluctuations in systemic blood pressure, have been suggested to play a role in the development of DCI. Pressure reactivity index (PRx) is a well-established measure of cerebral pressure autoregulation that has been used to study traumatic brain injury, but not extensively in SAH. OBJECTIVE: To study the relation between PRx and CBF in SAHpatients, and to examine if PRx can be used to predict DCI. METHODS: Retrospective analysis of prospectively collected data. PRx was calculated as the correlation coefficient between mean arterial blood pressure (MABP) and intracranial pressure (ICP) in a 5 min moving window. CBF was measured using bedside Xenon-CT (Xe-CT). DCI was diagnosed clinically. RESULTS: 47 poor-grade mechanically ventilated patients were studied. Patients with disturbed pressure autoregulation (high PRx values) had lower CBF, as measured by bedside Xe-CT; both in the early (day 0-3) and late (day 4-14) acute phase of the disease. PRx did not differ significantly between patients who developed DCI or not. CONCLUSION: In mechanically ventilated and sedated SAHpatients, high PRx (more disturbed CBF pressure autoregulation) is associated with low CBF, both day 0-3 and day 4-14 after onset. The role of PRx as a monitoring tool in SAHpatients needs further studying.
Authors: Tim Howells; Kristin Elf; Patricia A Jones; Elisabeth Ronne-Engström; Ian Piper; Pelle Nilsson; Peter Andrews; Per Enblad Journal: J Neurosurg Date: 2005-02 Impact factor: 5.115
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Jonathan A Friedman; Mark A Pichelmann; David G Piepgras; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Douglas A Nichols; Fredric B Meyer; John L D Atkinson; Eelco F M Wijdicks Journal: Neurosurgery Date: 2003-05 Impact factor: 4.654
Authors: Dennis J Nieuwkamp; Larissa E Setz; Ale Algra; Francisca H H Linn; Nicolien K de Rooij; Gabriël J E Rinkel Journal: Lancet Neurol Date: 2009-06-06 Impact factor: 44.182
Authors: Ricardo C Nogueira; Marcel Aries; Jatinder S Minhas; Nils H Petersen; Li Xiong; Jana M Kainerstorfer; Pedro Castro Journal: J Cereb Blood Flow Metab Date: 2021-09-13 Impact factor: 6.960
Authors: Teodor Svedung Wettervik; Timothy Howells; Anders Lewén; Elisabeth Ronne-Engström; Per Enblad Journal: Neurocrit Care Date: 2021-01-09 Impact factor: 3.210
Authors: Teodor Svedung Wettervik; Henrik Engquist; Anders Hånell; Timothy Howells; Elham Rostami; Elisabeth Ronne-Engström; Anders Lewén; Per Enblad Journal: Neurocrit Care Date: 2022-04-21 Impact factor: 3.532
Authors: Elham Rostami; Henrik Engquist; Timothy Howells; Elisabeth Ronne-Engström; Pelle Nilsson; Lars Tomas Hillered; Anders Lewén; Per Enblad Journal: Front Neurol Date: 2017-08-02 Impact factor: 4.003
Authors: Ulf Johnson; Henrik Engquist; Anders Lewén; Tim Howells; Pelle Nilsson; Elisabeth Ronne-Engström; Elham Rostami; Per Enblad Journal: Acta Neurochir (Wien) Date: 2017-03-30 Impact factor: 2.216